X4 Pharmaceuticals (XFOR) Gross Profit Growth (1y) (2025 - 2026)

X4 Pharmaceuticals (XFOR) Gross Profit Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 11.24%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 15.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 68.41%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 33.01%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -41.93%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 57.16%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 351.57%
10 X4 Pharmaceuticals 533.17 Mn 338.08 Mn 7.19 Mn 336.49%

Historic Data

Download Data
DateValue
Jun 30, 2026 336.49%
Dec 31, 2025 94.70%
Sep 30, 2025 324.62%
Jun 30, 2025 458.31%